07:00 , Oct 7, 2013 |  BC Week In Review  |  Clinical News

Deep TMS: Final clinical trial data

Final data from a double-blind, Israeli trial in 25 patients with OCD who failed to respond to both pharmacological and psychological therapy showed that high-frequency Deep TMS led to a significant mean improvement of 27%...
08:00 , Jan 21, 2013 |  BC Week In Review  |  Clinical News

Deep TMS regulatory update

Brainsway said FDA approved Deep TMS to treat depression in patients who have failed prior therapy with antidepressants. The company said it is exploring "various avenues" for marketing and distribution of the product in the...
07:00 , Jul 9, 2012 |  BC Week In Review  |  Clinical News

Deep TMS: Interim data

Interim data from 9 evaluable patients with OCD in a double-blind, Israeli trial showed that Deep TMS led to an improvement in Y-BOCS scores from baseline in 40% of patients vs. 0% of patients treated...
07:00 , Oct 24, 2011 |  BC Week In Review  |  Clinical News

Deep TMS neurology data

Interim data from an Israeli trial in 24 patients with AD showed that high-frequency (10 Hz) Deep TMS for 8 weeks improved ADAS-Cog score from baseline by 4.2 points vs. 1.8 points for sham control....
07:00 , May 16, 2011 |  BC Week In Review  |  Clinical News

Deep TMS neurology data

Pooled data from about 60 subjects in 3 Israeli exploratory trials showed that two sets of parameters for Deep TMS significantly reduced UPDRS scores vs. sham control at day 30 (p<0.01 and p<0.001). Two other...